                         SEQUENCE LISTING

<110>  ModernaTX, Inc.
 
<120>  METHODS OF PREPARING MODIFIED RNA

<130>  MRNA-040/001WO

<150>  US 62/547,682
<151>  2017-08-18

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  chemically synthesized RNA

<400>  1
caaaggctct tttcagagcc acca                                              24


<210>  2
<211>  24
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  chemically synthesized RNA

<400>  2
caaaggcucu uuucagagcc acca                                              24


<210>  3
<211>  26
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  chemically synthesized RNA


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  5'-triphosphate

<400>  3
gaguaagaag aaauauaaga gccacc                                            26


<210>  4
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  chemically synthesized RNA


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  7-methylguanosine

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  5'-triphosphate

<400>  4
ggggacuaga cugaacugga ca                                                22


<210>  5
<211>  10
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  partial stem loop polynucleotide sequence

<400>  5
gcagacugua                                                              10


<210>  6
<211>  17
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  partial stem loop polynucleotide sequence

<400>  6
gcagacugua aaucugc                                                      17


